Stephen Kennedy
Technik-/Wissenschafts-/F&E-Leiter bei CRISPR THERAPEUTICS AG
Profil
Stephen R. Kennedy bekleidet die Position des Head-Technical Operations bei der CRISPR Therapeutics AG. In seiner bisherigen Laufbahn war Stephen R. Kennedy Executive Vice President-Research & Development bei Mascoma Corp, Senior Vice President & Head-Technical Operations bei Casebia Therapeutics LLC, Principal bei Eastman Kodak Co, Chief Operating Officer & Executive Vice President bei Histogenics Corp, Principal bei Genencor International, Inc, Senior VP-Biologics Technical Operations bei Genzyme Corp. und Executive Director-MIT Center am Massachusetts Institute of Technology. Stephen R. Kennedy erwarb einen MBA an der Boston University, einen Graduiertenabschluss an der University of Rochester und einen Bachelor-Abschluss an der University of Michigan.
Aktive Positionen von Stephen Kennedy
Unternehmen | Position | Beginn |
---|---|---|
CRISPR THERAPEUTICS AG | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2019 |
Ehemalige bekannte Positionen von Stephen Kennedy
Unternehmen | Position | Ende |
---|---|---|
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2019 |
OCUGEN, INC. | Geschäftsführer | 22.03.2019 |
Mascoma Corp.
Mascoma Corp. BiotechnologyHealth Technology Mascoma Corp. develops technology for abundant biomass conversion. The firm operates through its bioprocessing technology platform, develops bioengineered yeasts and other microorganisms. It also designs and manufactures equipment that processes cellulosic biomass for further biological or chemical conversion. The company was founded by Lee R. Lynd, Charles E. Wyman and Robert J. Johnsen in 2005 and is headquartered in Waltham, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2013 |
Massachusetts Institute of Technology | Corporate Officer/Principal | 01.05.2011 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2010 |
Ausbildung von Stephen Kennedy
Boston University | Masters Business Admin |
Rochester Christian University | Graduate Degree |
University of Michigan | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
EASTMAN KODAK COMPANY | Producer Manufacturing |
CRISPR THERAPEUTICS AG | Health Technology |
Private Unternehmen | 7 |
---|---|
Mascoma Corp.
Mascoma Corp. BiotechnologyHealth Technology Mascoma Corp. develops technology for abundant biomass conversion. The firm operates through its bioprocessing technology platform, develops bioengineered yeasts and other microorganisms. It also designs and manufactures equipment that processes cellulosic biomass for further biological or chemical conversion. The company was founded by Lee R. Lynd, Charles E. Wyman and Robert J. Johnsen in 2005 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Health Technology |
Sweet Natural Trading Co. Ltd.
Sweet Natural Trading Co. Ltd. Food: Specialty/CandyConsumer Non-Durables Sweet Natural Trading Co. Ltd. engages in the provision of consumer-packaged goods with natural sweetener-based products such as xylitol and coconut sugar. It operates through the Canada and United States geographical segments. It offers candies; bread; cereal; snacks; dips and spreads; drinks; condiments, dressing, and sauces; baking products, pasta, and chocolate. The company was founded by Andrew Reid and Julie Reid in 2004 and is headquartered in Toronto, Canada. | Consumer Non-Durables |
Histogenics Corp.
Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Health Technology |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |